ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 80 filers reported holding ODONATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,000 | -98.0% | 18,017 | -95.6% | 0.00% | – |
| Q3 2021 | $1,181,000 | -71.8% | 405,899 | -66.1% | 0.00% | -100.0% |
| Q2 2021 | $4,181,000 | +966.6% | 1,198,210 | +945.1% | 0.00% | – |
| Q1 2021 | $392,000 | -96.3% | 114,648 | -79.1% | 0.00% | -100.0% |
| Q4 2020 | $10,509,000 | +45591.3% | 547,367 | +31484.9% | 0.00% | – |
| Q3 2020 | $23,000 | -95.0% | 1,733 | -84.0% | 0.00% | – |
| Q2 2020 | $458,000 | -75.7% | 10,828 | -84.1% | 0.00% | -100.0% |
| Q1 2020 | $1,882,000 | -52.6% | 68,134 | -44.3% | 0.00% | 0.0% |
| Q4 2019 | $3,970,000 | -4.4% | 122,331 | -23.3% | 0.00% | 0.0% |
| Q3 2019 | $4,151,000 | +12.5% | 159,444 | +58.6% | 0.00% | 0.0% |
| Q2 2019 | $3,689,000 | +26.7% | 100,529 | -23.6% | 0.00% | 0.0% |
| Q1 2019 | $2,911,000 | +129.4% | 131,668 | +46.2% | 0.00% | – |
| Q4 2018 | $1,269,000 | +440.0% | 90,070 | +643.9% | 0.00% | – |
| Q3 2018 | $235,000 | -27.0% | 12,107 | -17.0% | 0.00% | – |
| Q2 2018 | $322,000 | +0.6% | 14,593 | -3.4% | 0.00% | – |
| Q1 2018 | $320,000 | +263.6% | 15,099 | +329.2% | 0.00% | – |
| Q4 2017 | $88,000 | – | 3,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |